Determinants of utilisation differences for cancer medicines in Belgium, Scotland and Sweden.

Eur J Health Econ · 2017 · PMC5641289 · PMID 27942986

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Fifth, I did not have access to dispensing data at sub-national, and, therefore, could not control for differences in dispensing at that level, which may be significant.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.